Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
WASHINGTON, US: GlaxoSmithKline won US antitrust approval to buy Novartis AG’s vaccine business, with the exception of influenza vaccines, said the two companies. The deal is part of a three-way transaction unveiled in April 2014, which includes Britain’s GSK buying the vaccines business of Novartis, the Swiss company purchasing GSK’s cancer drugs, and the two groups tying up in consumer healthcare. The US Federal Trade Commission had previously announced that it approved the consumer health care joint venture on the condition that Novartis sell its Habitrol nicotine patch.
© Reuters News
Login
LOS ANGELES, US: A pair of researchers from the University of California, Los Angeles (UCLA) Henry Samueli School of Engineering and Applied Scie ...
ANN ARBOR, US: The spaghetti-like internal structure of most plastics makes it hard for them to cast away heat, but a University of Michigan research ...
TOKYO, JAPAN: Asahi Kasei Chemicals has completed the construction of a plant in China for Duranol polycarbonatediol (PCD), an intermediate for high-p ...
FRANKFURT, GERMANY: Scientists in Germany have developed a spectroscopy method to measure diabetics' glucose levels through their skin. When a sample ...
LUDWIGSHAFEN, GERMANY: BASF announced plans for a major investment in a pioneering superabsorbent technology platform of its hygiene business. BASF wi ...
GAINESVILLE, US: Human waste may have a new use: sending NASA spacecraft from the moon back to Earth. Until now, the waste has been collected to burn ...
Stay updated with the latest chemical industry trends and innovations.